Report Code : CVMI24073857 | Published Date : July 17, 2024

Market Overview
The U.S. clinical nutrition market is experiencing sustained growth driven by an aging population, a high burden of chronic disease, and an increasing demand for integrated hospital and home-based nutrition therapy. Clinical nutrition is now a critical element of treatment plans for oncology, diabetes, cardiovascular, and gastrointestinal disorders. With established reimbursement structures under Medicare, Medicaid, and commercial payers, as well as the rising adoption of digital health technologies, the U.S. is a global leader in clinical nutrition innovation.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

13.9

Includes inpatient, outpatient, and homecare-based enteral, parenteral, and oral nutrition

2024

20.3

CAGR 7.9% (2019–2024); fueled by ICU protocols and chronic disease prevalence

2031

32.1

CAGR 6.9% (2024–2031); personalized and digital nutrition platforms gain traction

 

Market Drivers

  • High prevalence of obesity, diabetes, cancer, and cardiovascular conditions requiring dietary interventions
  • Advanced hospital-based nutrition protocols and malnutrition screening practices
  • Growth in post-acute care and home enteral/parenteral nutrition services
  • Strong payer support under CMS for specific disease-linked nutrition therapies
  • Rise of AI-powered dietary planning and remote monitoring tools

 

Market Challenges

  • Gaps in home nutrition reimbursement, particularly in rural states
  • Safety risks and complications with long-term parenteral nutrition (e.g., CLABSI)
  • Cost-related patient drop-off from prescribed ONS in uninsured populations
  • Variability in hospital nutrition team staffing across facilities

 

Competitive Landscape

Company

2024 Share

Market Strengths

Notable Developments

Abbott Nutrition

25%

Glucerna, Ensure, hospital-adopted lines

Launched AI diet prescription platform for cancer patients (Q2 2025)

Nestlé Health Science

20%

Peptamen, Boost, GI and pediatric nutrition

Partnered with U.S. oncology networks for tube feed protocols (2024)

Danone Nutricia

14%

Adult recovery and renal nutrition

Expanded plant-based formulations for metabolic patients (2024)

Fresenius Kabi

12%

Parenteral nutrition and compounding kits

Acquired home infusion service provider (Q3 2024)

Others (Baxter, B. Braun, regional players)

29%

Specialty products and hospital supply contracts

Focused on pediatric and home IV segments

 

Market Segmentation
By Product Type:

  • Enteral Nutrition (EN) – 51%
  • Parenteral Nutrition (PN) – XX%
  • Oral Nutritional Supplements (ONS) – XX%

 

By End User:

  • Hospitals & Specialty Clinics – 49%
  • Home Health Agencies – XX%
  • Long-Term Care Facilities – XX%

 

Regional Dynamics

  • Northeast & Midwest – High-volume tertiary hospitals with formalized nutrition pathways
  • South & West – Expanding homecare and chronic illness-based nutrition programs
  • Rural States – Gaps in dietitian access but growing tele-nutrition services

 

Recent Developments

  • Abbott launched SmartMeal AI for personalized oral nutrition in oncology
  • Fresenius integrated PN compounding tracking with Epic systems (2025)
  • Nestlé expanded coverage of Boost GI for Crohn’s and colitis patients

 

Strategic Outlook
The U.S. clinical nutrition market is poised to evolve through EHR-integrated therapy planning, payer-driven outcomes reporting, and home-based nutrition automation. Digital dietitians, smart pumps, and remote monitoring will reshape adherence and personalization by 2031.

 

Methodology

Clearview Market Insights conducted 104 interviews with U.S.-based clinical dietitians, hospital procurement leaders, and payer policy analysts. Forecasting relied on CMS reimbursement datasets, home infusion registry data, and AI adoption metrics.





Reasons To Buy

Image



Scope

Image
  • Abbott Laboratories (Abbott U.S.)
  • Nestlé USA (Nestlé Health Science)
  • Danone North America
  • Fresenius Kabi USA, LLC
  • Baxter International Inc.
  • B. Braun USA (B. Braun Melsungen AG)
  • Pfizer Inc.
  • Otsuka Pharmaceutical Companies
  • ConMed Corp
  • Vesco Medical, LLC

 

United States Clinical Nutrition Market Report

 

  1. 1. United States Clinical Nutrition Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 United States Clinical Nutrition Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. United States Clinical Nutrition Market Research Report - Preface
    1. 2.1 United States Clinical Nutrition Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product Type
      2. 2.1.2 By End User
      3. 2.1.3 By Region
  3. 3. United States Clinical Nutrition Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product Type, By End User, By Country
    3. 3.3. Opportunities – By Product Type, By End User, By Country
    4. 3.4. Trends – By Product Type, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. United States Clinical Nutrition Market Research Report – DROTs Impact Analysis
    1. 4. United States Clinical Nutrition Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. United States Clinical Nutrition Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Enteral Nutrition (EN)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Parenteral Nutrition (PN)
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Oral Nutritional Supplements (ONS)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. United States Clinical Nutrition Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals & Specialty Clinics
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Home Health Agencies
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Long-Term Care Facilities
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. United States Clinical Nutrition Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 United States Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By End User, and Region, 2024 - 2031
  1. 8. Competition Landscape
    1. 8.1 Strategic Dashboard of Top Market Players
    2. 8.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 8.2.1 Abbott Laboratories (Abbott U.S.)
      2. 8.2.2 Nestlé USA (Nestlé Health Science)
      3. 8.2.3 Danone North America
      4. 8.2.4 Fresenius Kabi USA LLC
      5. 8.2.5 Baxter International Inc.
      6. 8.2.6 B. Braun USA (B. Braun Melsungen AG)
      7. 8.2.7 Pfizer Inc.
      8. 8.2.8 Otsuka Pharmaceutical Companies
      9. 8.2.9 ConMed Corp
      10. 8.2.10 Vesco Medical LLC
  1. 9. Data Collection Method and Research Approach
  2. 10. Principal Presumptions and Acronyms